Cover Image

Apratoxin S10 as a dual-action modulator of receptor tyrosine kinases and tumor microenvironment: emerging anticancer insights from marine-derived analogs.

Fuente: PubMed

Saved in:

Bibliographic Details
Main Authors:	Dhyani, Praveen, Sati, Priyanka, Attri, Dharam Chand, Sharma, Eshita, Campagna, Erica, Atanassova, Maria, Caruso, Gianluca, Almarhoon, Zainab M, Calina, Daniela, Setzer, William N, Sharifi-Rad, Javad
Format:	Artículo científico
Language:	en
Published:	Medical oncology (Northwood, London, England) 2025
Subjects:	Humans Tumor Microenvironment Animals Receptor Protein-Tyrosine Kinases Antineoplastic Agents Neoplasms
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The roles of algal polysaccharides in modulating tumor immune microenvironment.
by: Wu, Yinfeng, et al.
Published: (2025)

Demethylmycemycin A, a dibenzoxazepinone from the marine-derived Dactylosporangium sp. OK1079, with prostate cancer suppressive effects via targeting BRK-FAK-STAT3 axis.
by: Elsbaey, Marwa, et al.
Published: (2026)

The novel marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol exhibits anticancer activity by regulating multiple signaling pathways in human glioblastoma cells: Blocking EGF signaling.
by: Yamaguchi, Masayoshi, et al.
Published: (2025)

Rewiring the inflammatory microenvironment to reverse ovarian failure: Immunomodulatory implications of finerenone.
by: Tsui, Kuan-Hao, et al.
Published: (2026)

Recent advances in targeting cancer stem cells by using nanomaterials.
by: Rahimkhoei, Vahid, et al.
Published: (2025)

A mechanosensitive circuit of FAK, ROCK, and ERK controls biomineral growth and morphology in the sea urchin embryo.
by: Layous, Majed, et al.
Published: (2025)

Marine Polysaccharides Modulating the Gut Microbiota-Immune Axis in Digestive Tract Tumors: An Update.
by: Wang, Lisheng, et al.
Published: (2026)

Immunocompetent tumor-on-a-chip: A translational tool for drug screening and cancer therapy.
by: Liang, Anqi, et al.
Published: (2025)

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.
by: Bourg, Stéphane, et al.
Published: (2026)

Self-Carrier Nanoagonist Enabling Positive Feedback Regulation of Cuproptosis-Immunity for Potent Antitumor Therapy.
by: Jiang, Minhao, et al.
Published: (2026)

Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.
by: Lin, Pei-Hsuan, et al.
Published: (2026)

TumorArchetypeR
by: Lütge, Mechthild, et al.
Published: (2026)

Ultrasonication-assisted green synthesis, in silico EGFR-binding analysis, and cytotoxic evaluation of nitro-perimidines for non-small cell lung cancer.
by: Gopinadh, Meera, et al.
Published: (2026)

Evolutionary analysis and immune-induced expression and mA modification of RIPK1 and RIPK2 in the miiuy croaker.
by: Xing, Qianru, et al.
Published: (2025)

Primary Cilia-Mediated Hedgehog Signaling Regulates Cell Fate During ER Stress-Induced Life or Death Decisions.
by: Xu, Jia, et al.
Published: (2025)

Implementation and preliminary evaluation of the Tumor Microenvironment of Co-Cultive HTB-125/HTB-126 in response to treatment with Potassium Ribose Ascorbate or Potassium Ribosate
by: Sánchez-Vega, María Gabriela, et al.
Published: (2024)

Synergistic induction of immunogenic cell death and tumor microenvironment remodeling by biotinylated marine polysaccharide nanoparticles for enhanced colorectal cancer therapy.
by: Wang, Hui, et al.
Published: (2026)

Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
by: Du, Lin, et al.
Published: (2025)

Computational Analysis of Azole Derivatives Targeting the PI3K/AKT/mTOR Pathway With In Vitro Cytotoxicity and Autophagy Evaluation.
by: Regurajan, Rathika, et al.
Published: (2026)

Anticancer Activity of the Marine-Derived Compound Bryostatin 1: Preclinical and Clinical Evaluation.
by: Kowalczyk, Tomasz, et al.
Published: (2025)

Rapid, multiplex, one-pot CRISPR/Dx system for detecting cancer fusion genes.
by: Li, Jiaqi, et al.
Published: (2025)

New Fusarochromanone Derivatives from the Marine Fungus UBOCC-A-117302.
by: Pham, Giang Nam, et al.
Published: (2024)

Antithrombotic Effect of L. Extract and Its Fractions via Regulating TLRs and the Downstream MAPKs and PI3K/AKT Signaling Pathways in Zebrafish.
by: Wang, Xiyue, et al.
Published: (2025)

Prognostic and predictive value of AXL and C-MET in patients with rectal cancer
by: Ribas, Carmen Australia Paredes Marcondes, et al.
Published: (2025)

Novel Fusion Protein Based on DR5-Specific TRAIL Variant with Enhanced Antitumor Properties.
by: Yagolovich, Anne V, et al.
Published: (2025)

Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
by: Cao, Yin, et al.
Published: (2025)

RNF34 negatively regulates innate immunity via ubiquitin-mediated TAK1 degradation in miiuy croaker (Miichthysmiiuy).
by: Dong, Wenjing, et al.
Published: (2025)

Antiproliferative and apoptotic effects of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) in oral cancer cells are mediated by oxidative stress and ERK activation.
by: Chuang, Ya-Ting, et al.
Published: (2025)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
by: Mao, Churu, et al.
Published: (2024)

Regulatory feedback between VEGF and ERK pathways controls tip-cell expression during sea urchin skeletogenesis.
by: Nehrer, Tovah, et al.
Published: (2025)

MEK1/2 inhibition prevents DENV and ZIKV infection via disrupting the cytoskeletal vimentin cage required for viral replication.
by: Huang, Yuhan, et al.
Published: (2026)

Low-molecular-weight polyphenol promotes cell sensitivity to cisplatin and alleviates cancer-related muscle atrophy via NF-κB suppression in oral squamous cell carcinoma.
by: Chang, Yun-Ching, et al.
Published: (2025)

Decoding melanoma's cellular mosaic to unlock immunotherapy potential.
by: Pozniak, Joanna, et al.
Published: (2025)

Tumor Microenvironment-Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer.
by: Zhu, Zihan, et al.
Published: (2025)

Pan-cancer analysis of CDC7 in human tumors: Integrative multi-omics insights and discovery of novel marine-based inhibitors through machine learning and computational approaches.
by: Saif, Ahmed, et al.
Published: (2025)

MSR1 in lung squamous cell carcinoma: Prognostic and immunological values in pan-cancer and single-cell analyses and a cohort study.
by: Bu, Yuxiang, et al.
Published: (2025)

Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities.
by: Wang, Zimin, et al.
Published: (2025)

The tolerance mechanism of diarrhetic shellfish toxins mediated by the extracellular regulated protein kinase (ERK) pathway in the mussel Perna viridis.
by: Lv, Jin-Jin, et al.
Published: (2025)

Computational Framework for pH-Responsive Control of Tumor Microenvironment and Immune Dynamics
by: Rosario Aloma, Enrique
Published: (2025)

Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
by: Chen, Xiaohui, et al.
Published: (2025)